Digital R&D: Transforming the future of clinical development
Transforming the future of clinical development
Biopharma R&D has changed the face of disease management over the years. Yet many in the field admit that clinical development has fallen behind in adopting digital technologies, which have the potential to change how research organizations can engage with patients, innovate in patient care, and execute processes to drive efficiencies. While digital transformation is a complex, resource-intensive, and lengthy undertaking, the rewards are well worth the effort.
Value-based care and medical technology
Assessing the value of medtech products and offerings
The health care ecosystem is in the midst of a shift from volume-based, fee-for-service (FFS) systems to value-based care (VBC) models. AdvaMed launched a Strategic Value Initiative with Deloitte Consulting LLP to develop principles and an approach for assessing the value of medical technologies.